SonarMD
Chicago, US · Delaware corporation · 5 known investors
SonarMD is a digital monitoring platform for patients with inflammatory bowel disease that uses validated questionnaires and proprietary algorithms to detect deteriorating gut health between clinical visits. The platform enables physicians and health plans to proactively intervene before disease flares, reducing emergency visits and hospitalizations while improving patient outcomes.
Founders & leadership
LR
LAWRENCE R KOSINSKIDirector
BH
BETH HOUCKinExecutive Officer, Director
JS
John StarrExecutive Officer
AH
Anna HaghgooieDirector
DG
Devin GrossExecutive Officer, Director
TM
THOMAS M SHEHABDirector
CT
CHARITY TARNDirector
RB
ROY BEVERIDGEDirector
Investors · 5
Reported raises · per SEC filings
Form D private placements▶$3MraisedMar 2026 · 1 investors · Other Health CareRule 506(b)
▶$3MraisedMar 2026 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Roy BeveridgeDirector
- Beth HouckExecutive Officer, Director
- Charity TarnDirector
- Tom CoxDirector
- Lawrence R. KosinskiDirector
- Offering amount
- $7M
- Amount sold
- $3M
- First sale
- Feb 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.2MraisedJan 2025 · 3 investors · Other Health CareRule 506(b)
▶$2.2MraisedJan 2025 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Charity TarnDirector
- Tom CoxDirector
- Lawrence R KosinskiDirector
- Beth HouckExecutive Officer, Director
- Beveridge RoyDirector
- Offering amount
- $3M
- Amount sold
- $2.2M
- Minimum investment
- $16.1K
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MraisedJul 2024 · 1 investors · Other Health CareRule 506(b)
▶$1MraisedJul 2024 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- LAWRENCE R KOSINSKIDirector
- BETH HOUCKExecutive Officer, Director
- THOMAS M SHEHABDirector
- ROY BEVERIDGEDirector
- CHARITY TARNDirector
- Offering amount
- $2M
- Amount sold
- $1M
- Minimum investment
- $1
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.3MraisedMay 2023 · 3 investors · Other Health CareRule 506(b)
▶$4.3MraisedMay 2023 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- LAWRENCE R KOSINSKIExecutive Officer, Director
- ROY BEVERIDGEDirector
- THOMAS M SHEHABDirector
- BETH HOUCKExecutive Officer, Director
- EMIR SANDHUDirector
- Offering amount
- $4.3M
- Amount sold
- $4.3M
- Minimum investment
- $2
- First sale
- Apr 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$32KraisedFeb 2020 · 24 investors · Other Health CareRule 506(b)
▶$32KraisedFeb 2020 · 24 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John StarrExecutive Officer
- Anna HaghgooieDirector
- Tom ShehabDirector
- Lawrence KosinskiExecutive Officer, Director
- Devin GrossExecutive Officer, Director
- Offering amount
- $32K
- Amount sold
- $32K
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.